FDA Green Lights Soliqua 100/33 for Type 2 Diabetes

[Northerner]

The FDA has approved Sanofi’s once-daily Soliqua 100/33 (insulin glargine and lixisenatide injection) for the treatment of adults with type 2 diabetes. It is indicated to improve blood sugar control in adults who are not controlled with basal insulin (less than 60 Units daily) or lixisenatide.

http://www.pharmacytimes.com/product-news/fda-green-lights-soliqua-10033-for-type-2-diabetes

Insulin with added lizard spit 🙂

 

[mikeyB]

Or they could eat less. I don't know how American physicians can put obese people on more and more medication to control their blood sugar. It's the wrong way to treat people, but I don't suppose that shows a profit for drug companies. I can't see this concoction appearing in the UK range of standard treatment.